ArticleFrontiers in oncology2021

Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.

Zhi-Dong Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.